Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | S215G |
Impact List | missense |
Protein Effect | loss of function |
Gene Variant Descriptions | TP53 S215G lies within the DNA-binding domain of the Tp53 protein (PMID: 15510160). S215G results in decreased Tp53 transactivation activity and leads to reduced apoptosis relative to wild type Tp53 in cell culture (PMID: 22862161). |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon6 TP53 S215G TP53 mutant TP53 inact mut TP53 S215G |
Transcript | NM_000546.6 |
gDNA | chr17:g.7674888T>C |
cDNA | c.643A>G |
Protein | p.S215G |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126114.3 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
NM_001126112.3 | chr17:g.7674888T>C | c.643A>G | p.S215G | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
TP53 S215G | lung non-small cell carcinoma | resistant | Seliciclib | Preclinical - Cell culture | Actionable | In a preclinical study, non-small cell lung carcinoma cells overexpressing TP53 S215G were resistant to Roscovotine (seliciclib) induced apoptosis in culture (PMID: 22862161). | 22862161 |